IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.159
EU - Europa 7.216
AS - Asia 5.768
SA - Sud America 1.435
AF - Africa 318
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
Totale 28.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.966
SG - Singapore 2.243
UA - Ucraina 1.474
BR - Brasile 1.175
CN - Cina 1.118
RU - Federazione Russa 832
IT - Italia 829
IE - Irlanda 822
SE - Svezia 791
DE - Germania 783
TR - Turchia 698
HK - Hong Kong 560
DK - Danimarca 530
VN - Vietnam 489
FI - Finlandia 368
FR - Francia 290
KR - Corea 288
GB - Regno Unito 258
CI - Costa d'Avorio 202
AR - Argentina 116
CA - Canada 84
IN - India 80
MX - Messico 80
BD - Bangladesh 51
EC - Ecuador 47
ID - Indonesia 46
ZA - Sudafrica 45
JP - Giappone 44
PL - Polonia 41
NL - Olanda 40
AT - Austria 30
MA - Marocco 29
IR - Iran 27
BE - Belgio 26
IQ - Iraq 26
PY - Paraguay 26
CO - Colombia 24
ES - Italia 19
RO - Romania 17
CL - Cile 13
PK - Pakistan 12
RS - Serbia 12
VE - Venezuela 12
EG - Egitto 11
EU - Europa 11
UZ - Uzbekistan 11
CH - Svizzera 10
DO - Repubblica Dominicana 10
LT - Lituania 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
NP - Nepal 9
AZ - Azerbaigian 8
BG - Bulgaria 8
UY - Uruguay 7
AU - Australia 6
DZ - Algeria 6
IL - Israele 6
KZ - Kazakistan 6
MY - Malesia 6
SA - Arabia Saudita 6
HR - Croazia 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
JO - Giordania 4
OM - Oman 4
AL - Albania 3
BO - Bolivia 3
CY - Cipro 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
GY - Guiana 2
HN - Honduras 2
KI - Kiribati 2
MN - Mongolia 2
PA - Panama 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
A1 - Anonimo 1
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
Totale 28.906
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.480
Singapore 1.338
Ashburn 1.323
Chandler 1.165
Fairfield 1.116
Dallas 1.039
Dublin 813
Boardman 744
Wilmington 583
Hong Kong 552
Woodbridge 484
New York 433
Seattle 403
Houston 394
Des Moines 339
Ann Arbor 334
Cambridge 333
Lawrence 314
Princeton 314
San Mateo 310
Beijing 290
Moscow 237
Abidjan 202
Los Angeles 199
Hefei 190
Ho Chi Minh City 181
San Diego 140
Centro 131
Munich 125
Turin 115
The Dalles 109
São Paulo 97
Hanoi 96
Buffalo 93
Redmond 66
Turku 62
London 58
Guangzhou 54
Chicago 53
Ancona 47
Shanghai 46
Norwalk 43
Izmir 40
Tokyo 37
Rio de Janeiro 36
Helsinki 33
Santa Clara 33
Warsaw 31
Johannesburg 30
Columbus 29
Da Nang 29
Wuhan 29
Belo Horizonte 28
Brooklyn 28
Denver 28
Montreal 28
Porto 28
Washington 28
Nuremberg 27
Mexico City 26
Phoenix 26
Rome 26
Brussels 25
Brasília 24
Pune 24
Atlanta 23
Orem 22
Salt Lake City 22
Chennai 21
Falls Church 21
Curitiba 20
Haiphong 20
Guayaquil 19
Ottawa 19
Stockholm 19
Wuxi 19
Poplar 17
Boston 16
Manchester 16
Marche 16
Dhaka 15
Kilburn 15
Biên Hòa 14
Jiaxing 14
Nanjing 14
Ninh Bình 14
San Francisco 14
Urbisaglia 14
Guarulhos 13
Jakarta 13
Ribeirão Preto 13
Vienna 13
Ankara 12
Asunción 12
Buenos Aires 12
Campinas 12
Cingoli 12
Elk Grove Village 12
Querétaro 12
Baghdad 11
Totale 17.669
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 296
Antimicrobial Resistance: A Challenge for the Future 265
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 233
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 209
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 177
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 176
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 174
Anticryptosporidial activity of paromomycin. 173
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 162
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 158
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 154
Antimicrobial activity of polycationic peptides 148
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 148
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 145
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 144
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 139
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 135
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 135
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 134
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 133
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 133
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 131
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 129
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 127
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 127
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 127
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 124
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 124
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 123
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 122
[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy] 121
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 121
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 120
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 120
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 119
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV. 119
Tocilizumab in COVID-19 interstitial pneumonia 119
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 118
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 118
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 116
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 116
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 116
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 116
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 115
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 114
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study 114
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 113
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 113
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 113
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 113
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 112
Animal models commonly used to study quorum-sensing inhibitors. 111
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 111
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 110
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 109
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 109
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 109
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 109
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 108
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 108
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 108
Epidemiology and microbiology of surgical wound infections. 107
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 107
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 107
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 106
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 105
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 105
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 105
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 104
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 104
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 104
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 104
Urinary catheters and biofilm formation 104
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 104
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 104
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 104
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 104
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 104
OC-34 Clinical outcome of switching to a dual drug regimen (2DR) vs. switching or remaining on a triple (3DR) regimen in the setting of a viral load ≤50 copies/mL 103
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 103
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 103
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 103
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 101
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 101
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 100
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 100
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 100
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 100
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 99
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 99
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 99
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 99
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 98
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 98
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 97
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 97
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 97
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 97
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes 97
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 97
Totale 12.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.688 0 0 0 0 0 297 432 301 473 479 477 229
2021/20222.517 215 539 25 123 34 174 124 149 167 297 193 477
2022/20233.933 409 368 294 271 284 624 7 206 1.023 20 303 124
2023/20242.292 430 45 137 379 406 470 34 63 21 25 37 245
2024/20254.916 646 419 288 131 165 238 447 190 1.102 304 441 545
2025/20266.497 758 1.131 1.178 1.625 1.273 532 0 0 0 0 0 0
Totale 29.362